Clover Biopharmaceuticals   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Chengdu China (2007)

Organization Overview

First Clinical Trial
2018
NCT03443674
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Clover Biopharmaceuticals AUS Pty Ltd | CLOVER PHARMS | Zhejiang Clover Biopharmaceuticals, Inc.